Lung Cancer |
|
|
Clinical Trial: Combination Chemotherapy Plus Radiation Therapy With or Without Gefitinib in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
This study is currently recruiting patients.
Purpose
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Biological therapies such as gefitinib may interfere with the growth of the tumor cells and slow the growth of tumors. It is not yet known whether combination chemotherapy plus radiation therapy is more effective with or without gefitinib in treating non-small cell lung cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy plus radiation therapy with or without gefitinib in treating unresectable stage III non-small cell lung cancer.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Squamous Cell Lung Cancer large cell lung cancer stage IIIA non-small cell lung cancer stage IIIB non-small cell lung cancer Adenocarcinoma of the Lung Bronchoalveolar Cell Lung Cancer | Drug: cisplatin Drug: docetaxel Drug: etoposide Drug: gefitinib Procedure: chemotherapy Procedure: enzyme inhibitor therapy Procedure: protein tyrosine kinase inhibitor therapy Procedure: radiation therapy | Phase III |
MedlinePlus related topics: Lung Cancer
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Randomized Study of Cisplatin, Etoposide, Radiotherapy, and Docetaxel With or Without Gefitinib in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
OBJECTIVES:
- Compare cisplatin, etoposide, radiotherapy, and docetaxel with or without gefitinib, in terms of improving overall survival and progression-free survival, in patients with unresectable stage III non-small cell lung cancer.
- Determine the toxicity profile of gefitinib in these patients.
OUTLINE: This is a randomized, double-blind, multicenter study. Patients are stratified according to performance status (0 vs 1), stage (stage IIIA vs IIIB), measurability of lesion (measurable vs nonmeasurable), and histologic subtype (squamous vs nonsquamous).
Patients receive induction therapy comprising cisplatin IV over 1 hour on days 1, 8, 29, and 36 and etoposide IV over 1 hour on days 1-5 and 29-33. Beginning within 24 hours after starting chemotherapy, patients receive concurrent induction radiotherapy 5 days a week for 5 weeks and then boost radiotherapy 5 days a week for 1.5 weeks.
Beginning approximately 4-8 weeks after completion of chemoradiotherapy, patients with stable or responding disease receive consolidation therapy comprising docetaxel IV over 1 hour on day 1. Treatment repeats every 21 days for 3 courses.
Patients with stable or responding disease are randomized to one of two treatment arms for maintenance therapy. Patients begin maintenance therapy approximately 4-7 weeks after completion of consolidation therapy.
- Arm I: Patients receive oral gefitinib daily.
- Arm II: Patients receive oral placebo daily. In both arms, maintenance therapy continues for a maximum of 5 years in the absence of disease progression or unacceptable toxicity.
Patients are followed every 6 months for 5 years and then annually for 5 years.
PROJECTED ACCRUAL: A total of 840 patients will be accrued for this study within 3.5 years.
Eligibility
Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Histologically or cytologically confirmed newly diagnosed single, primary bronchogenic non-small cell lung cancer (NSCLC)
- Adenocarcinoma
- Non-lobar and non-diffuse bronchoalveolar cell carcinoma
- Large cell carcinoma
- Squamous cell carcinoma
- Unresectable stage IIIA disease
- Histologically or cytologically confirmed N2 status
- Multiple and/or bulky mediastinal lymph nodes on CT scan or x-ray
- Ineligible for induction chemotherapy or chemoradiotherapy followed by surgical resection
- Ineligible for or refused participation in SWOG-9336 OR
- Stage IIIB disease
- Pathologically or radiographically documented positive N3 nodes
- No positive supraclavicular or scalene lymph nodes with disease extending up into the cervical region OR
- Any documented T4 lesions invading the mediastinum, heart, great vessels, trachea, esophagus, vertebral body, or carina
- Mediastinal involvement without organ involvement allowed if soft tissue mass extends directly into the mediastinum
- Radiographic criteria for involvement of main pulmonary artery allowed if mediastinal soft tissue mass is present
- Single primary parenchymal lesion
- No other lesions on same or opposite sides of the lung
- No metastatic disease involving the contralateral chest, liver, or adrenals by CT scan of upper abdomen
- No malignant pleural or pericardial effusions
- Pleural effusions visible only on CT scan or too small to tap allowed
- Measurable or evaluable disease by CT scan, MRI, x-ray, or physical exam
- No brain metastases
PATIENT CHARACTERISTICS: Age:
- Not specified
Performance status:
- Zubrod 0-1
Life expectancy:
- Not specified
Hematopoietic:
- WBC at least 3,000/mm^3
- Absolute neutrophil count at least 1,500/mm^3
- Platelet count at least 100,000/mm^3
Hepatic:
- Not specified
Renal:
- Creatinine clearance at least 50 mL/min
Pulmonary:
- FEV
- at least 2.0 L OR
- FEV_1 less than 2.0 L if predicted FEV_1 of the contralateral lung is greater than 800 mL by quantitative split function testing
Other:
- No other malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer or carcinoma in situ of the cervix
- No other concurrent non-cancer-related illness that would preclude study therapy
- Not pregnant or nursing
- Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY: Biologic therapy:
- No concurrent colony-stimulating factors during induction therapy
Chemotherapy:
- See Disease Characteristics
- No prior chemotherapy for NSCLC
Endocrine therapy:
- Not specified
Radiotherapy:
- See Disease Characteristics
- No prior radiotherapy for NSCLC
Surgery:
- No prior surgical resection of NSCLC
- Prior exploratory thoracotomy, mediastinoscopy, excisional biopsy, or similar diagnostic or staging surgery allowed
Location and Contact Information
Alabama
MBCCOP - Gulf Coast, Mobile, Alabama, 36607, United States; Recruiting
Arizona
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, 85724, United States; Recruiting
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, 85259-5404, United States; Recruiting
CCOP - Western Regional, Arizona, Phoenix, Arizona, 85006-2726, United States; Recruiting
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden), Phoenix, Arizona, 85012, United States; Recruiting
Veterans Affairs Medical Center - Tucson, Tucson, Arizona, 85723, United States; Recruiting
Arkansas
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States; Recruiting
Veterans Affairs Medical Center - Little Rock, Little Rock, Arkansas, 72205, United States; Recruiting
California
CCOP - Bay Area Tumor Institute, Oakland, California, 94609-3305, United States; Recruiting
CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, 95403, United States; Recruiting
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, 92868, United States; Recruiting
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, 90095-1781, United States; Recruiting
University of California Davis Cancer Center, Sacramento, California, 95817, United States; Recruiting
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, 90033, United States; Recruiting
Veterans Affairs Medical Center - Loma Linda (Pettis), Loma Linda, California, 92357, United States; Recruiting
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, 94553, United States; Recruiting
Colorado
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora, Colorado, 80010, United States; Recruiting
Veterans Affairs Medical Center - Denver, Denver, Colorado, 80220, United States; Recruiting
District of Columbia
MBCCOP - Howard University Cancer Center, Washington, District of Columbia, 20060, United States; Recruiting
Florida
Mayo Clinic - Jacksonville, Jacksonville, Florida, 32224, United States; Recruiting
Veterans Affairs Medical Center - Tampa (Haley), Tampa, Florida, 33612, United States; Recruiting
Georgia
CCOP - Atlanta Regional, Atlanta, Georgia, 30342-1701, United States; Recruiting
Hawaii
MBCCOP - Hawaii, Honolulu, Hawaii, 96813, United States; Recruiting
Illinois
Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, 60153-5500, United States; Recruiting
CCOP - Carle Cancer Center, Urbana, Illinois, 61801, United States; Recruiting
CCOP - Central Illinois, Decatur, Illinois, 62526, United States; Recruiting
CCOP - Illinois Oncology Research Association, Peoria, Illinois, 61615-7828, United States; Recruiting
MBCCOP - University of Illinois at Chicago, Chicago, Illinois, 60612, United States; Recruiting
Swedish-American Regional Cancer Center, Rockford, Illinois, 61104-2315, United States; Recruiting
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, 60612, United States; Recruiting
Veterans Affairs Medical Center - Hines, Hines, Illinois, 60141, United States; Recruiting
Iowa
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, 52403-1206, United States; Recruiting
CCOP - Iowa Oncology Research Association, Des Moines, Iowa, 50309-1016, United States; Recruiting
Siouxland Hematology-Oncology, Sioux City, Iowa, 51101-1733, United States; Recruiting
Kansas
CCOP - Wichita, Wichita, Kansas, 67214-3882, United States; Recruiting
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, 66160-7353, United States; Recruiting
Veterans Affairs Medical Center - Wichita, Wichita, Kansas, 67218, United States; Recruiting
Kentucky
Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington, Kentucky, 40536-0084, United States; Recruiting
Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, 40502-2236, United States; Recruiting
Louisiana
CCOP - Ochsner, New Orleans, Louisiana, 70121, United States; Recruiting
Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, 71130-3932, United States; Recruiting
MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, 70112, United States; Recruiting
Tulane Cancer Center at Tulane University Hospital and Clinic, New Orleans, Louisiana, 70112, United States; Recruiting
Veterans Affairs Medical Center - New Orleans, New Orleans, Louisiana, 70112, United States; Recruiting
Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, 71101-4295, United States; Recruiting
Massachusetts
Cancer Research Center at Boston Medical Center, Boston, Massachusetts, 02118, United States; Recruiting
Michigan
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201-1379, United States; Recruiting
CCOP - Beaumont, Royal Oak, Michigan, 48073-6769, United States; Recruiting
CCOP - Grand Rapids, Grand Rapids, Michigan, 49503, United States; Recruiting
CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, 48106, United States; Recruiting
Josephine Ford Cancer Center at Henry Ford Health System, Detroit, Michigan, 48202, United States; Recruiting
Providence Cancer Institute at Providence Hospital - Southfield, Southfield, Michigan, 48075, United States; Recruiting
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109-0948, United States; Recruiting
Veterans Affairs Medical Center - Detroit, Detroit, Michigan, 48201-1932, United States; Recruiting
Minnesota
CCOP - Duluth, Duluth, Minnesota, 55805, United States; Recruiting
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, 55416, United States; Recruiting
Coborn Cancer Center, Saint Cloud, Minnesota, 56303, United States; Recruiting
Mayo Clinic Cancer Center, Rochester, Minnesota, 55905, United States; Recruiting
St. Mary's - Duluth Clinic Cancer Center, Duluth, Minnesota, 55805, United States; Recruiting
Mississippi
University of Mississippi Medical Center, Jackson, Mississippi, 39216-4505, United States; Recruiting
Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, 39216, United States; Recruiting
Missouri
CCOP - Cancer Research for the Ozarks, Springfield, Missouri, 65807, United States; Recruiting
CCOP - Kansas City, Kansas City, Missouri, 64131, United States; Recruiting
CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, 63141, United States; Recruiting
Saint Louis University Cancer Center, Saint Louis, Missouri, 63110, United States; Recruiting
Montana
CCOP - Montana Cancer Consortium, Billings, Montana, 59101, United States; Recruiting
Nebraska
CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, 68106, United States; Recruiting
New Mexico
MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, 87131, United States; Recruiting
Veterans Affairs Medical Center - Albuquerque, Albuquerque, New Mexico, 87108-5138, United States; Recruiting
New York
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, 10032, United States; Recruiting
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, 14642, United States; Recruiting
NYU Cancer Institute at New York University Medical Center, New York, New York, 10016, United States; Recruiting
North Carolina
CCOP - Southeast Cancer Control Consortium, Goldsboro, North Carolina, 27534-9479, United States; Recruiting
North Dakota
Altru Cancer Center, Grand Forks, North Dakota, 58201, United States; Recruiting
CCOP - Merit Care Hospital, Fargo, North Dakota, 58122, United States; Recruiting
Medcenter One Health System, Bismarck, North Dakota, 58501-5505, United States; Recruiting
Ohio
CCOP - Columbus, Columbus, Ohio, 43206, United States; Recruiting
CCOP - Dayton, Dayton, Ohio, 45429, United States; Recruiting
Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, 45267-0501, United States; Recruiting
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195-9001, United States; Recruiting
Veterans Affairs Medical Center - Cincinnati, Cincinnati, Ohio, 45220-2288, United States; Recruiting
Veterans Affairs Medical Center - Dayton, Dayton, Ohio, 45428-1002, United States; Recruiting
Oklahoma
CCOP - Oklahoma, Tulsa, Oklahoma, 74136, United States; Recruiting
Oklahoma University Medical Center, Oklahoma City, Oklahoma, 73104, United States; Recruiting
Oregon
Cancer Institute at Oregon Health and Science University, Portland, Oregon, 97201-3098, United States; Recruiting
CCOP - Columbia River Oncology Program, Portland, Oregon, 97225, United States; Recruiting
Veterans Affairs Medical Center - Portland, Portland, Oregon, 97207, United States; Recruiting
Pennsylvania
Allegheny General Hospital, Pittsburgh, Pennsylvania, 15212-4772, United States; Recruiting
CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, 17822-2001, United States; Recruiting
South Carolina
CCOP - Greenville, Greenville, South Carolina, 29615, United States; Recruiting
CCOP - Upstate Carolina, Spartanburg, South Carolina, 29303, United States; Recruiting
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, 29425, United States; Recruiting
Veterans Affairs Medical Center - Charleston, Charleston, South Carolina, 29401-5799, United States; Recruiting
South Dakota
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, 57104, United States; Recruiting
Rapid City Regional Hospital, Rapid City, South Dakota, 57709, United States; Recruiting
Tennessee
University of Tennessee Cancer Institute at Methodist Central Hospital, Memphis, Tennessee, 38104, United States; Recruiting
Veterans Affairs Medical Center - Memphis, Memphis, Tennessee, 38104, United States; Recruiting
Texas
Brooke Army Medical Center, Fort Sam Houston, Texas, 78234-6200, United States; Recruiting
CCOP - Scott and White Hospital, Temple, Texas, 76508, United States; Recruiting
Harrington Cancer Center, Amarillo, Texas, 79106, United States; Recruiting
MD Anderson Cancer Center at University of Texas, Houston, Texas, 77030-4095, United States; Recruiting
Medical City Dallas Hospital, Dallas, Texas, 75230, United States; Recruiting
University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229-3900, United States; Recruiting
University of Texas Medical Branch, Galveston, Texas, 77555-0565, United States; Recruiting
Veterans Affairs Medical Center - Amarillo, Amarillo, Texas, 79106, United States; Recruiting
Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, 78229, United States; Recruiting
Veterans Affairs Medical Center - Temple, Temple, Texas, 76504, United States; Recruiting
Utah
Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, 84112-5550, United States; Recruiting
Veterans Affairs Medical Center - Salt Lake City, Salt Lake City, Utah, 84148, United States; Recruiting
Washington
CCOP - Northwest, Tacoma, Washington, 98405-0986, United States; Recruiting
CCOP - Virginia Mason Research Center, Seattle, Washington, 98101, United States; Recruiting
Puget Sound Oncology Consortium, Seattle, Washington, 98109, United States; Recruiting
Veterans Affairs Medical Center - Seattle, Seattle, Washington, 98108, United States; Recruiting
Canada
Centre Hospitalier Regional de Rimouski, Quebec, G1S 4L8, Canada; Recruiting
Canada, Alberta
Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada; Recruiting
Lethbridge Cancer Clinic, Lethbridge, Alberta, T1J 1W5, Canada; Recruiting
Canada, British Columbia
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, V1Y 5L3, Canada; Recruiting
British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria, British Columbia, V8R 6V5, Canada; Recruiting
British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada; Recruiting
G. Steinhoff Clinical Research, Victoria, British Columbia, V8V 3N1, Canada; Recruiting
Lions Gate Hospital, North Vancouver, British Columbia, V7L 2P9, Canada; Recruiting
Nanaimo Cancer Clinic at Nanaimo Regional General Hospital, Nanaimo, British Columbia, V9S 2B7, Canada; Recruiting
Prostate Centre at Vancouver General Hospital, Vancouver, British Columbia, V5Z 3J5, Canada; Recruiting
Providence Health Care - Vancouver, Vancouver, British Columbia, V6Z 1Y6, Canada; Recruiting
Canada, Manitoba
CancerCare Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada; Recruiting
Canada, New Brunswick
Doctor Leon Richard Oncology Centre, Moncton, New Brunswick, E1C 8X3, Canada; Recruiting
Moncton Hospital, Moncton, New Brunswick, E1C 6ZB, Canada; Recruiting
Saint John Regional Hospital, Saint John, New Brunswick, E2L 4L2, Canada; Recruiting
Canada, Newfoundland and Labrador
Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, A1B 3V6, Canada; Recruiting
Canada, Nova Scotia
Cape Breton Cancer Centre, Sydney, Nova Scotia, B1P 1P3, Canada; Recruiting
Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, B3H 1V7, Canada; Recruiting
Canada, Ontario
Algoma Regional Cancer Program at Sault Area Hospital, Sault Sainte Marie, Ontario, P6A 2C4, Canada; Recruiting
Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor, Ontario, N8W 2X3, Canada; Recruiting
Cancer Centre of Southeastern Ontario, Kingston, Ontario, K7L 5P9, Canada; Recruiting
Durham Regional Cancer Centre at Lakeridge Health Oshawa, Oshawa, Ontario, L1G 2B9, Canada; Recruiting
Grand River Regional Cancer Centre at Grand River Hospital, Kitchner, Ontario, N2G 1G3, Canada; Recruiting
Hamilton and District Urology Research Group, Hamilton, Ontario, L8N 1T8, Canada; Recruiting
Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines, Ontario, L2R 5K3, Canada; Recruiting
Humber River Regional Hospital - Weston, Weston, Ontario, M9N 1N8, Canada; Recruiting
London Health Sciences Centre, London, Ontario, N6A 4G5, Canada; Recruiting
Male Health Centre - North York, Toronto, Ontario, M6A 3B5, Canada; Recruiting
Male Health Centre - Oakville, Oakville, Ontario, L6H 3PI, Canada; Recruiting
Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, L8V 5C2, Canada; Recruiting
Markham Stouffville Hospital, Markham, Ontario, L6B IAI, Canada; Recruiting
Mount Sinai Hospital - Toronto, Toronto, Ontario, M5G 1X5, Canada; Recruiting
North York General Hospital, Ontario, North York, Ontario, M2K 1E1, Canada; Recruiting
Northeastern Ontario Regional Cancer Centre, Sudbury, Ontario, P3E 5J1, Canada; Recruiting
Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus, Ottawa, Ontario, K1H 8L6, Canada; Recruiting
Peterborough Oncology Clinic, Peterborough, Ontario, K9H 7B6, Canada; Recruiting
Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada; Recruiting
Regional Cancer Care at Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, P7B 6V4, Canada; Recruiting
Royal Victoria Hospital of Barrie, Barrie, Ontario, L4M 6M2, Canada; Recruiting
Scarborough Hospital - General Site, Scarborough, Ontario, M1P 2V5, Canada; Recruiting
Southlake Regional Health Centre, Newmarket, Ontario, L3Y 2P9, Canada; Recruiting
St. Joseph's Health Centre - Toronto, Toronto, Ontario, M6R 1B5, Canada; Recruiting
St. Michael's Hospital - Toronto, Toronto, Ontario, M5B 1W8, Canada; Recruiting
Sunnybrook and Women's College Health Sciences Centre, North York, Ontario, M4N 3M5, Canada; Recruiting
Toronto East General Hospital, Toronto, Ontario, M4C 3E7, Canada; Recruiting
Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, M4N 3M5, Canada; Recruiting
Trillium Health Centre - Mississauga, Mississauga, Ontario, L5B 1B8, Canada; Recruiting
William Osler Health Centre, Brampton, Ontario, L6W 2Z8, Canada; Recruiting
Canada, Prince Edward Island
Prince Edward Island Cancer Centre at Queen Elizabeth Hospital, Charlottetown, Prince Edward Island, C1A 8T5, Canada; Recruiting
Canada, Quebec
Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, (P.Q.) H2X 3J4, Canada; Recruiting
Centre Hospitalier Regional de Lanaudiere, Joliette, Quebec, J6E 6J2, Canada; Recruiting
Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, G1R 2J6, Canada; Recruiting
CHUS-Hopital Fleurimont, Sherbrooke, Quebec, J1H 5N4, Canada; Recruiting
Complexe Hospitalier de la Sagamie, Chicoutimi, Quebec, G7H 5H6, Canada; Recruiting
Hopital Charles Lemoyne, Greenfield Park, Quebec, J4V 2H1, Canada; Recruiting
Hopital Du Sacre-Coeur de Montreal, Montreal, Quebec, H4J 1C5, Canada; Recruiting
Hopital du Saint-Sacrement, Quebec, Quebec City, Quebec, G1S 4L8, Canada; Recruiting
Hopital Sainte Justine, Montreal, Quebec, H3T 1C5, Canada; Recruiting
Hotel Dieu de Montreal, Montreal, Quebec, H2W 1T8, Canada; Recruiting
Hotel-Dieu de Levis, Levis, Quebec, G6V 3Z1, Canada; Recruiting
L'Hopital Laval, Ste Foy, Quebec, G1V 4G5, Canada; Recruiting
Maisonneuve-Rosemont Hospital, Montreal, Quebec, H1T 2M4, Canada; Recruiting
Canada, Saskatchewan
Saskatoon Cancer Centre, Saskatoon, Saskatchewan, S7N 4H4, Canada; Recruiting
Karen Kelly, MD, Study Chair, University of Colorado Cancer Center
James R. Jett, MD, Study Chair, Mayo Clinic Cancer Center
Yee C. Ung, MD, FRCPC, Study Chair, Toronto Sunnybrook Regional Cancer Centre
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: March 2005
Last Updated: April 4, 2005
Record first received: July 11, 2001
ClinicalTrials.gov Identifier: NCT00020709
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


